System Xc−: a key regulatory target of ferroptosis in cancer
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, F., & Yang, Y. P. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3068-6 · Cited by 18
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
Chu, B., Kon, N., Chen, D., Li, T., Liu, T., Jiang, L., Song, S., Tavana, O., & Gu, W. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0305-6 · Cited by 882
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H.-F., Zhang, J., Wang, H., Chen, X., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0380-z · Cited by 809
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
The SLC3 and SLC7 families of amino acid transporters
Fotiadis, D., Kanai, Y., & Palacín, M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.007 · Cited by 680
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Louandre, C., Ezzoukhry, Z., Godin, C., Barbare, J., Mazière, J., Chauffert, B., & Galmiche, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28159 · Cited by 602
Bridges, R. J., Natale, N. R., & Patel, S. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01480.x · Cited by 538
Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
Yang, Y., Luo, M., Zhang, K., Zhang, J., Gao, T., Connell, D. O., Yao, F., Mu, C., Cai, B., Shang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14324-x · Cited by 480
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 477
Lipoxygenase‐mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3
Shintoku, R., Takigawa, Y., Yamada, K., Kubota, C., Yoshimoto, Y., Takeuchi, T., Koshiishi, I., & Torii, S. (2017) · Cancer Science · doi:10.1111/cas.13380 · Cited by 447
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421
Sato, M., Kusumi, R., Hamashima, S., Kobayashi, S., Sasaki, S., Komiyama, Y., Izumikawa, T., Conrad, M., Bannai, S., & Sato, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19213-4 · Cited by 403
Louandre, C., Marcq, I., Bouhlal, H., Lachaier, E., Godin, C., Saidak, Z., François, C., Chatelain, D., Debuysscher, V., Barbare, J.-C., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.014 · Cited by 374
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Heidi, C., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 350
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Liu, D. S., Duong, C. P., Haupt, S., Montgomery, K. G., House, C. M., Azar, W. J., Pearson, H. B., Fisher, O. M., Read, M., Guerra, G. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14844 · Cited by 321
Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors
Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y., & Sontheimer, H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5258-04.2005 · Cited by 316
Dixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314
Robert, S. M., Buckingham, S. C., Campbell, S. L., Robel, S., Holt, K. T., Ogunrinu-Babarinde, T., Warren, P. P., White, D. M., Reid, M. A., Eschbacher, J. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8103 · Cited by 301
Cysteine dioxygenase 1 mediates erastin-induced ferroptosis in human gastric cancer cells
Hao, S., Yu, J., He, W., Huang, Q., Zhao, Y., Liang, B., Zhang, S., Wen, Z., Dong, S., Rao, J., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2017.10.005 · Cited by 276
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271
Kim, E. H., Shin, D., Lee, J., Jung, A. R., & Roh, J.-L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.018 · Cited by 261
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Singer, E., Judkins, J., Salomonis, N., Matlaf, L., Soteropoulos, P., McAllister, S., & Soroceanu, L. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.566 · Cited by 249
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Jiang, L., Hickman, J. H., Wang, S.-J., & Gu, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1068479 · Cited by 231
Qi, W., Li, Z., Xia, L., Dai, J., Zhang, Q., Wu, C., & Xu, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52837-8 · Cited by 226
Yamaguchi, Y., Kasukabe, T., & Kumakura, S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4259 · Cited by 225
Yu, H., Yang, C., Jian, L., Guo, S., Chen, R., Li, K., Qu, F., Tao, K., Fu, Y., Luo, F., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.7189 · Cited by 222
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO reports · doi:10.15252/embr.201847563 · Cited by 214
Liu, N., Lin, X., & Huang, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0660-x · Cited by 212
Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT
Wang, Z., Ding, Y., Wang, X., Lu, S., Wang, C., He, C., Wang, L., Piao, M., Chi, G., Luo, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.021 · Cited by 210
Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 208
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Yoshikawa, M., Tsuchihashi, K., Ishimoto, T., Yae, T., Motohara, T., Sugihara, E., Onishi, N., Masuko, T., Yoshizawa, K., Kawashiri, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3609-t · Cited by 191
Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7598 · Cited by 191
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Gnanapradeepan, K., Basu, S., Barnoud, T., Budina-Kolomets, A., Kung, C.-P., & Murphy, M. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00124 · Cited by 178
Sleire, L., Skeie, B. S., Netland, I. A., Førde, H. E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J. I., Pedersen, P.-H., Wang, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.60 · Cited by 175
How do we fit ferroptosis in the family of regulated cell death?
Fearnhead, H. O., Vandenabeele, P., & Berghe, T. V. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.149 · Cited by 175
Arensman, M. D., Yang, X. S., Leahy, D. M., Toral-Barza, L., Mileski, M., Rosfjord, E. C., Wang, F., Deng, S., Myers, J. S., Abraham, R. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814932116 · Cited by 171
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
Chen, R.-S., Song, Y.-M., Zhou, Z.-Y., Tong, T., Li, Y., Fu, M., Guo, X.-L., Dong, L.-J., He, X., Qiao, H.-X., et al. (2009) · Oncogene · doi:10.1038/onc.2008.414 · Cited by 164
Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
Bai, T., Lei, P., Zhou, H., Liang, R., Zhu, R., Wang, W., Zhou, L., & Sun, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14594 · Cited by 156
Gai, C., Yu, M., Li, Z., Wang, Y., Ding, D., Zheng, J., Lv, S., Zhang, W., & Li, W. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29221 · Cited by 152
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 151
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
Zhou, H., Xu, C. Y., Cai, L., Nan, X.-W., Chen, J.-H., Chen, X., Yang, Y., Xing, Z.-H., Wei, M.-N., Li, Y., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01398 · Cited by 150
Houessinon, A., François, C., Sauzay, C., Louandre, C., Mongelard, G., Godin, C., Bodeau, S., Takahashi, S., Saidak, Z., Gutierrez, L., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0526-2 · Cited by 137
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Lanzardo, S., Conti, L., Rooke, R., Ruiu, R., Accart, N., Bolli, E., Arigoni, M., Macagno, M., Barrera, G., Pizzimenti, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1208 · Cited by 134
Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134
Non-Canonical Cell Death Induced by p53
Ranjan, A., & Iwakuma, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122068 · Cited by 134
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11858 · Cited by 129
Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 127
MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells
Bai, T., Liang, R., Zhu, R., Wang, W., Zhou, L., & Sun, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29496 · Cited by 125
Huang, C., Yang, M., Deng, J., Li, P., Su, W., & Jiang, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6585 · Cited by 119
SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., & Aboody, K. S. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0123 · Cited by 104
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Takeuchi, S., Wada, K., Toyooka, T., Shinomiya, N., Shimazaki, H., Nakanishi, K., Nagatani, K., Otani, N., Osada, H., Uozumi, Y., et al. (2013) · Neurosurgery · doi:10.1227/neu.0b013e318276b2de · Cited by 103
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint-Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 102
Okazaki, S., Shintani, S., Hirata, Y., Suina, K., Semba, T., Yamasaki, J., Umene, K., Ishikawa, M., Saya, H., & Nagano, O. (2018) · Oncotarget · doi:10.18632/oncotarget.26112 · Cited by 94
Okazaki, S., Umene, K., Yamasaki, J., Suina, K., Otsuki, Y., Yoshikawa, M., Minami, Y., Masuko, T., Kawaguchi, S., Nakayama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14182 · Cited by 88
Ju, H., Lu, Y., Chen, D.-L., Tian, T., Mo, H., Wei, X., Liao, J.-W., Wang, F., Zeng, Z.-L., Pelicano, H., et al. (2016) · Theranostics · doi:10.7150/thno.14848 · Cited by 87
Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., Nakamura, T., Abe, M., Masuda, A., Sakaue, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13728 · Cited by 81
Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
Zhang, W., Gai, C., Ding, D., Wang, F., & Li, W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00507 · Cited by 80
Ye, J., Jiang, X., Dong, Z., Hu, S., & Xiao, M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s217944 · Cited by 79
xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells
Bekeschus, S., Eisenmann, S., Sagwal, S. K., Bodnar, Y., Moritz, J., Poschkamp, B., Stoffels, I., Emmert, S., Madesh, M., Weltmann, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101423 · Cited by 72
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 71
Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer.
Sugano, K., Maeda, K., Ohtani, H., Nagahara, H., Shibutani, M., & Hirakawa, K. (2015) · PubMed · Cited by 65
Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
Shin, S., Jeong, B., Wall, B., Li, J., Shan, N. L., Wen, Y., Goydos, J. S., & Chen, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0098-7 · Cited by 65
Otsubo, K., Nosaki, K., Imamura, C. K., Ogata, H., Fujita, A., Sakata, S., Hirai, F., Toyokawa, G., Iwama, E., Harada, T., et al. (2017) · Cancer Science · doi:10.1111/cas.13309 · Cited by 61
Linher‐Melville, K., Haftchenary, S., Gunning, P. T., & Singh, G. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2412-4 · Cited by 60
Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K., Kosaka, T., Mikami, S., Saya, H., & Oya, M. (2019) · Cancer Science · doi:10.1111/cas.13960 · Cited by 60
Roh, J., Kim, E. H., Jang, H.-J., & Shin, D. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.002 · Cited by 57
Shiozaki, A., Iitaka, D., Ichikawa, D., Nakashima, S., Fujiwara, H., Okamoto, K. K., Kubota, T., Komatsu, S., Kosuga, T., Takeshita, H., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0847-5 · Cited by 55
Ruiu, R., Rolih, V., Bolli, E., Barutello, G., Riccardo, F., Quaglino, E., Merighi, I. F., Pericle, F., Donofrío, G., Cavallo, F., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2185-1 · Cited by 52
Ma, Z., Zhang, H., Lian, M., Yue, C., Dong, G., Jin, Y., Li, R., Wan, H., Wang, R., Wang, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5976 · Cited by 51
Dahlmanns, M., Yakubov, E., Chen, D., Sehm, T., Rauh, M., Savaskan, N. E., & Dahlmanns, J. K. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.30 · Cited by 47
Wang, H., Liu, C., Zhao, Y., Zhang, W., Xu, K., Li, D., Zhou, Y., Li, H., Xiao, G., Lü, B., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.187 · Cited by 43
Sauzay, C., Louandre, C., Bodeau, S., Anglade, F., Godin, C., Saidak, Z., Fontaine, J., Usureau, C., Martin, N., Molinié, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23843 · Cited by 38
Horibe, S., Kawauchi, S., Tanahashi, T., Sasaki, N., Mizuno, S., & Rikitake, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.055 · Cited by 33
Otsuki, Y., Yamasaki, J., Suina, K., Okazaki, S., Koike, N., Saya, H., & Nagano, O. (2019) · Cancer Science · doi:10.1111/cas.14224 · Cited by 33
Wolf, I. M. L., Fan, Z., Rauh, M., Seufert, S., Hore, N., Buchfelder, M., Savaskan, N. E., & Eyüpoglu, I. Y. (2014) · Scientific Reports · doi:10.1038/srep06226 · Cited by 30
Suina, K., Tsuchihashi, K., Yamasaki, J., Kamenori, S., Shintani, S., Hirata, Y., Okazaki, S., Sampetrean, O., Baba, E., Akashi, K., et al. (2018) · Cancer Science · doi:10.1111/cas.13826 · Cited by 30
Linher‐Melville, K., Nashed, M. G., Ungard, R. G., Haftchenary, S., Rosa, D. A., Gunning, P. T., & Singh, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161202 · Cited by 24
Yang, F. (2014) · Cited by 13
Cited by
Ferroptosis as a potential target for cancer therapy
Chen, Z., Wang, W., Abdul Razak, S. R., Han, T., Ahmad, N. H., & Li, X. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05930-w · Cited by 193
Amino acid metabolism, redox balance and epigenetic regulation in cancer
Li, X., & Zhang, H. (2024) · The FEBS Journal · doi:10.1111/febs.16803 · Cited by 90
Ferritin in ferroptosis: implications for neurodegenerative diseases (Review)
Chen, W., Tian, H., Wei, R., Chen, X., & Jia, Y. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5790 · Cited by 12
“It is a heterodimeric transport complex composed of heavy chain solute carrier family 3 member 2 (SLc3A2; 4F2hc) and light chain SLc7A11 (xcT) (27).”
Metadata
- Authors
- Liu, M.-R., Zhu, W.-T., & Pei, D.-S.
- Venue
- Investigational New Drugs
- Published
- 2021-01-27
- Volume
- 39
- Issue
- 4
- Pages
- 1123-1131
- ISSN
- 0167-6997 (ISSN-L)
- 1573-0646
- OpenAlex
- W3122552054
- Cited by
- 254
- References
- 89
- FWCI
- 22.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.